Clinical Trial Update: S0337, Gemcitabine After Surgery in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating gemcitabine after surgery for newly diagnosed or recurrent bladder cancer completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Bladder Cancer | Phase 3 | Status: COMPLETED | Results posted: 2018-04-24